SEC Form D private-offering filing

NextCure, Inc.

A new SEC Form D private-offering notice from Beltsville, MD, a $21,500,000 filer-stated offering target in Biotech. The source filing is one click away.

NextCure, Inc. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing immunomedicines and antibody drug conjugates to treat cancer.

Filed 2025-12-10Filed to raise $21,500,000First money in 2025-11-12Raised so far $21,500,000HQ (as filed) Beltsville, MDSector Biotech ✓Stage (inferred) EarlyCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified nextcure.com↗Named in the filing 12 executives & directors
Open this row on the live feed →More new filings in Maryland →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.